News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

06:00 ET

United Therapeutics Corporation Reports Second Quarter 2014 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2014. "Our...

Jul 22, 2014, 06:00 ET

United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2014 financial results before market...

Jun 27, 2014, 06:00 ET

United Therapeutics Announces Additional $500 Million Share Repurchase Program

 United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional...

May 06, 2014, 06:00 ET
Apr 29, 2014, 06:00 ET

United Therapeutics Corporation Reports First Quarter 2014 Financial Results

- Revenues of $289.4 million - Net income of $137.5 million - Earnings per Share of $2.73 per Basic Share or $2.43 per Diluted...

Apr 22, 2014, 06:00 ET

United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2014 financial results before market...

Mar 26, 2014, 06:00 ET

Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin

United Therapeutics Corporation (NASDAQ: UTHR) today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for...

Feb 25, 2014, 06:00 ET

United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results

  - Total Annual Revenues of $1.1 billion - Annual Earnings per Share of $3.49 per Basic Share or $3.28 per Diluted Share -...

Feb 18, 2014, 06:00 ET

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2013 financial results...

Dec 20, 2013, 20:01 ET

FDA Approves Orenitram™ (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...

Dec 09, 2013, 06:00 ET

United Therapeutics Receives Subpoena From Office of Inspector General

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has received a subpoena from the Office of the Inspector General...

Oct 29, 2013, 06:00 ET

United Therapeutics Corporation Reports Third Quarter 2013 Financial Results

- Revenues of $302.2 million - Earnings per Share of $1.25 per Basic Share or $1.17 per Diluted Share - Non-GAAP Earnings of...

Oct 22, 2013, 06:00 ET

United Therapeutics Corporation to Announce Third Quarter 2013 Financial Results Before Market Open on Tuesday, October 29, 2013

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2013 financial results before market...

Sep 11, 2013, 17:00 ET

United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has...

Jul 25, 2013, 06:00 ET

United Therapeutics Corporation Reports Second Quarter 2013 Financial Results

  - Total Revenues of $280.6 million - Earnings per Share of $1.60 per Basic Share or $1.52 per Diluted Share - Earnings...

Jul 18, 2013, 06:00 ET

United Therapeutics Corporation to Announce Second Quarter 2013 Financial Results Before Market Open on Thursday, July 25, 2013

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2013 financial results before market...

Apr 25, 2013, 06:00 ET

United Therapeutics Corporation Reports First Quarter 2013 Financial Results

- Total Revenues of $245.1 million - Earnings per Share of $1.24 per Basic Share or $1.19 per Diluted Share - Earnings Before...

Apr 18, 2013, 06:00 ET

United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2013 financial results before market...

Mar 25, 2013, 05:00 ET

United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it received a second complete response letter from the United States Food...

Feb 26, 2013, 06:00 ET

United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge